An infectious disease specialist discusses HIV prevention barriers facing Black women and how long-acting options and ...

Ropeginterferon alfa-2b-njft is expected to be available immediately.

Christos Vaklavas, MD, discusses geographic and telehealth barriers to cancer care access across Utah and the broader ...

Among 56,978 Dutch adults, occupational irritants (OR, 1.19), cleaning products (1.25), and mites (1.41) tracked with ...

Ninety-six percent of the study population also had confirmed chronic traumatic encephalopathy on autopsy.

Among cause-specific cardiovascular deaths, evolocumab showed directionally favorable effects for acute MI, stroke, and heart ...

NHANES cross-sectional modeling showed cardiovascular health associated with lower overactive bladder prevalence. Component ...

In honor of Blood Cancer Awareness Month, this special Director’s Cut episode of Managed Care Cast features a conversation ...

Christos Vaklavas, MD, is a professor and breast cancer oncologist at the University of Utah Huntsman Cancer Institute.

Eman Toraih, MD, PhD, MSc, DBio, is a research faculty volunteer in the Cardiovascular Perfusion Department at SUNY Upstate Medical University, NY, USA, and professor of medical genetics at Suez Canal ...

The choice of therapy at first relapse in multiple myeloma has grown considerably more complex as chimeric antigen receptor (CAR) T-cell therapy, bispecific antibody combinations, ...

Shiven B. Patel, MD, MBA, discussed strategies for overcoming tissue limits, delays, and rural access gaps in NSCLC biomarker testing at an IVBM event.